Home > Insider Trading > Filing (0001209191-16-155974)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368148	Athersys Inc / New	ATHX	Pharmaceutical Preparations (2834)	204864095

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402609	Jr William Lehmann	3201 Carnegie Avenue Cleveland OH 44115-2634	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-12-17	5,358	$1.59	395,101	No	4	F	Direct
Common Stock	Disposition	2016-12-19	3,000	$1.60	392,101	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the minimum tax withholding obligation.
Shares sold pursuant to a predefined Rule 10b5-1 trading plan enacted solely related to the tax obligation.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.61, inclusive, in accordance with a previously established Rule 10b5-1 predefined trading plan enacted solely related to the tax obligation.
Securities beneficially owned are comprised of: (1) 203,755 shares of common stock owned and (2) unvested restricted stock units aggregating 188,346 related to annual awards, which vest quarterly over a four-year period from grant date.